Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bulnes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Molecular Neuroscience : MN|October 6, 2007
VEGF immunopositivity related to malignancy degree, proliferative activity and angiogenesis in ENU-induced gliomasS Bulnes, J V Lafuente
Histology and Histopathology|April 2, 2009
Microvascular adaptive changes in experimental endogenous brain gliomasS Bulnes, J Bilbao, J V Lafuente
Amino Acids|October 10, 2002
Role of VEGF in an experimental model of cortical micronecrosisJ V Lafuente, S Bulnes, B Mitre, et al.
Revista De Neurologia|December 13, 2006
[Tumour induction by ethylnitrosourea in the central nervous system]S Bulnes-Sesma, N Ullibarri-Ortiz de Zárate, J V Lafuente-Sánchez
Acta Neurochirurgica. Supplement|October 9, 2009
The role of eNOS in vascular permeability in ENU-induced gliomasS Bulnes, E G Argandoña, H Bengoetxea, et al.
Acta Neurochirurgica. Supplement|October 9, 2009
Effects of VEGF administration or neutralization on the BBB of developing rat brainN Ortuzar, E G Argandoña, H Bengoetxea, et al.
Molecular Neurobiology|March 6, 2018
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's DiseaseC Requejo, J A Ruiz-Ortega, H Bengoetxea, et al.
Molecular Neurobiology|August 26, 2017
Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's DiseaseC Requejo, J A Ruiz-Ortega, H Bengoetxea, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Molecular Neuroscience : MN|October 6, 2007
VEGF immunopositivity related to malignancy degree, proliferative activity and angiogenesis in ENU-induced gliomasS Bulnes, J V Lafuente
Histology and Histopathology|April 2, 2009
Microvascular adaptive changes in experimental endogenous brain gliomasS Bulnes, J Bilbao, J V Lafuente
Amino Acids|October 10, 2002
Role of VEGF in an experimental model of cortical micronecrosisJ V Lafuente, S Bulnes, B Mitre, et al.
Revista De Neurologia|December 13, 2006
[Tumour induction by ethylnitrosourea in the central nervous system]S Bulnes-Sesma, N Ullibarri-Ortiz de Zárate, J V Lafuente-Sánchez
Acta Neurochirurgica. Supplement|October 9, 2009
The role of eNOS in vascular permeability in ENU-induced gliomasS Bulnes, E G Argandoña, H Bengoetxea, et al.
Acta Neurochirurgica. Supplement|October 9, 2009
Effects of VEGF administration or neutralization on the BBB of developing rat brainN Ortuzar, E G Argandoña, H Bengoetxea, et al.
Molecular Neurobiology|March 6, 2018
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's DiseaseC Requejo, J A Ruiz-Ortega, H Bengoetxea, et al.
Molecular Neurobiology|August 26, 2017
Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's DiseaseC Requejo, J A Ruiz-Ortega, H Bengoetxea, et al.
Pageof 1